Not yet recruiting NCT07376187

Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases

No phase Interventional Chronic Suppurative Lung Disease Protracted Bacterial Bronchitis Primary Ciliary Dyskinesia (PCD) Non Cystic Fibrosis Bronchiectasis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Videoconferencing (Vsee platform), Specially designed website (FysΑΩ).
Who it may be relevant to: Registry conditions: Chronic Suppurative Lung Disease, Protracted Bacterial Bronchitis, Primary Ciliary Dyskinesia (PCD), Non Cystic Fibrosis Bronchiectasis. Basic parameters: 6 years — 12 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Greece
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Digital Physiotherapy Services in the Management of Pediatric Chronic Suppurative Lung Diseases: A Randomized Controlled Trial

Overview

Detailed description

This is a prospective, single-center, two-arm (1:1), assessor-blinded, randomized controlled clinical trial that will be conducted in collaboration with the outpatient clinic of the third Pediatric Pulmonology Unit, "Attikon" University Hospital of Athens in Greece. The aim of the study is to investigate the effects of applying digital physiotherapy services in the management of specific clinical outcomes in children with chronic suppurative lung diseases, other than cystic fibrosis. The collection of medical history will be conducted via a 40-minute synchronous videoconference session. Children will be randomized into parallel arms: the digital health services group (DHSG) and the control group (CG). All children will receive usual care, including inhaled antibiotics and/or bronchodilators for respiratory infections, alongside recommendations to maintain regular physical activity and to perform ACTs. Furthermore, all child-parent/caregiver dyads will attend a 40-minute, in-person session with the physiotherapist at the outpatient clinic. This session is designed to provide standardized training on airway clearance techniques (ACTs) for subsequent implementation at home. The DHSG will undergo a 12-week home-based hybrid (synchronous and asynchronous), remotely administered exercise program and ACTs. Likewise, the DHSG will have access to a specifically designed website about disease management (www.fysao.gr). The intervention program includes airway clearance techniques (ACTs), as well as aerobic and strengthening exercises that can be implemented easily in an online setting at home with minimal equipment. The prescribed weekly regimen will consist of 50-minute remote sessions: two synchronous, 1:1 supervised sessions conducted via videoconferencing, and a minimum of one asynchronous, unsupervised session. All outcome measures will be assessed at the following time points: baseline (before the intervention), the end of the intervention (12 weeks), and follow-up (6 months after the intervention has ended). All clinical assessments will be conducted in-person at the outpatient clinic by blinded healthcare professionals. Changes from baseline in functional and exercise capacity, compliance with ACTs, respiratory and peripheral muscle strength, physical activity and sedentary behavior, as well as quality of life, will be assessed at 3 and 6 months for both groups.

Interventions

Device Videoconferencing (Vsee platform)
The prescribed weekly regimen will consist of 50-minute remote sessions: two synchronous, supervised sessions conducted via the Vsee platform, and a minimum of one asynchronous, unsupervised session. Children will perform ACTs (including individualized teaching and review of postural drainage, percussion, vibration, ACTs devices, huffing, coughing), diaphragmatic breathing, and blowing games. During the synchronous, supervised videoconference sessions, they will be monitored/supervised by the pe
Device Specially designed website (FysΑΩ)
The DHSG will be granted access to a website (www.fysao.gr) for disease management, including information about common symptoms, nutrition, pharmacological treatment, exercise, and ACTs performance. To facilitate adherence and longitudinal monitoring, the DHSG will receive automated weekly reminders for ACTs and exercise performance. Through the web portal's integrated evaluation forms, children can report daily symptomatology and track any clinical fluctuations. All the ACTs and the exercise pr

Primary outcome measures

Exercise Capacity (modified Shuttle Walk test) [Time frame: Change From Baseline in MSWT distance at 3 and 6 months]
Compliance with the airway clearance techniques and exercise program [Time frame: Change From Baseline at 3 and 6 months in: symptomatology, frequency, and duration of ACTs performance, as well as frequency and duration of exercise program performed]

Secondary outcome measures (10)

Functional Capacity [Time frame: Change From Baseline in 6MWT distance at 3 and 6 months]
Exercise Capacity (Chester Step test) [Time frame: Change From Baseline in CST steps at 3 and 6 months]
Respiratory muscle strength [Time frame: Change From Baseline in MIP and MEP scores at 3 and 6 months]
Peripheral muscle strength [Time frame: Change From Baseline in handgrip scores at 3 and 6 months]
Physical Activity (Physical Activity Questionnaire for Older Children) [Time frame: Change From Baseline in PAQ-C Score at 3 and 6 months]
Physical Activity and Sedentary Behavior (Youth Activity Profile) [Time frame: Change From Baseline in YAP Score at 3 and 6 months]
Health-Related Quality of Life [Time frame: Change From Baseline in PedsQL Score at 3 and 6 months]
Cough-specific Quality of Life [Time frame: Change From Baseline in CC-QoL Score at 3 and 6 months]
Sleep Quality [Time frame: Change From Baseline in PSQ Score at 3 and 6 months]
Digital Health Services Satisfaction [Time frame: TUQ Score after 12 weeks (end of the intervention)]

Eligibility criteria

Inclusion criteria

children aged 6 to 12 years old
clinically stable with an absence of pulmonary exacerbation four weeks prior to the study's recruitment
adherence to attend regular medical follow-up from a pediatric pulmonologist every three months

Exclusion criteria

Cystic fibrosis
Immunodeficiency or asthma as their primary condition
Clinical evidence of cardiovascular, neuromuscular, metastatic, or psychiatric comorbidities, and neuromuscular or musculoskeletal impairments that affect mobility and the ability to follow instructions
Medical history of lung transplant
Participation in other rehabilitation programs, or attendance at regular physiotherapy ACTs sessions (>10 sessions in a 3-month period)
Lack access to the internet (e.g., no smartphone, tablet, or laptop)
Inability to use technological devices

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation: Randomized
Model: Parallel assignment
Masking: Single blind
Primary purpose: Treatment

Study locations

Greece · 1 center

Physiotherapy Department, University of Thessaly — Lamia

Publications

ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. PMID 12091180

Identifiers

NCT: NCT07376187 · 22510/25

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗